封面
市场调查报告书
商品编码
1609984

萤光血管造影术市场规模、份额、趋势分析报告:按类型、应用、最终用途、地区、细分市场预测,2025-2030 年

Fluorescein Angiography Market Size, Share & Trends Analysis Report By Type (Traditional Fluorescein Angiography), By Application (Age-related Macular Degeneration), By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

萤光血管造影术市场成长与趋势

Grand View Research, Inc.的最新报告显示,到2030年终,全球萤光素血管造影术市场规模预计将达到13.9亿美元,2025年至2030年复合年增长率为8.5%。黄斑部病变和糖尿病视网膜病变等眼部疾病的盛行率不断上升以及技术的快速进步是一些影响市场的驱动因素。然而,人们对 OCT 和眼底萤光等更安全、更快速的替代品的日益偏好预计将阻碍预测期内的市场成长。

该国的医院和诊断成像中心等终端用户已有效采用基于人工智慧的眼底摄影机来检测各种致盲疾病。例如,2019年1月,广东省德清县医院使用中山大学与百度(一家提供搜寻引擎平台等服务的中国跨国科技公司)共同开发的AI摄像头,为我们进行免费体检,以发现疾病。这款AI眼底摄影机可以诊断青光眼、糖尿病视网膜病变、黄斑部病变。

萤光素血管造影术经常被用作多种眼科疾病的确诊测试,儘管其替代方案是首选。该技术提供准确、高品质的影像,有助于高效的治疗方法选择。此外,开发中国家对传统萤光血管造影术的需求仍然很高。这是由于负担能力和产品可用性。

萤光血管血管造影术市场报告亮点

  • 传统萤光血管造影术占据市场主导地位,2024 年占最大收益占有率为 56.4%。
  • 老龄化黄斑部病变(AMD)应用将在2024年占据最大的收益占有率,达到32.6%,由于这种疾病在老龄化人群中的患病率不断增加,占据市场主导地位。
  • 医院和诊所领域引领市场,2024 年占最大收益占有率,达 63.9%。
  • 北美萤光素血管造影术市场主导全球市场,2024年占最大收益占有率为36.4%。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章萤光血管造影术市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章萤光血管造影术市场:类型业务分析

  • 类型市场占有率,2024 年和 2030 年
  • 类型细分仪表板
  • 2018-2030 年市场规模、预测与趋势分析(按类型)
  • 传统萤光造影(FA)
  • 共焦扫描雷射检眼镜 (cSLO) FA

第五章萤光血管造影术市场:应用商业分析

  • 2024年及2030年应用市场占有率
  • 使用细分仪表板
  • 2018-2030 年市场规模、预测与趋势分析(按应用)
  • 老龄化黄斑部病变(AMD)
  • 糖尿病视网膜病变
  • 视网膜静脉阻塞
  • 葡萄膜炎和视网膜血管炎
  • 脉络膜肿瘤
  • 其他的

第六章萤光血管造影术市场:最终用途商业分析

  • 2024 年及 2030 年最终用途市场占有率
  • 最终用途细分仪表板
  • 2018-2030 年按最终用途分類的市场规模、预测与趋势分析
  • 医院/诊所
  • 门诊手术中心
  • 其他的

第 7 章萤光血管造影术市场:区域、估计与趋势分析

  • 2024 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 参与者概览
  • 公司市场分析
  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • Carl Zeiss Meditec, Inc.
    • NIDEK Co., Ltd.
    • Kowa Company Ltd.
    • Topcon Medical Systems, Inc.
    • Optomed Oy Ltd.
    • CenterVue SpA
    • Canon, Inc.
Product Code: GVR-4-68038-554-0

Fluorescein Angiography Market Growth & Trends:

The global fluorescein angiography market size is expected to reach USD 1.39 billion by the end of 2030, expanding at a CAGR of 8.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of ophthalmic conditions such as macular degeneration and diabetic retinopathy and rapid technological advancements are some of the high impact-rendering market drivers. However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.

End-users such as hospitals and imaging centers in the country are effectively adopting AI-based fundus cameras for detecting various blindness-causing diseases. For instance, in January 2019, Deqing County hospital in Guangdong Province conducted a free consultation by featuring an AI camera codeveloped by Sun Yat-sen University and Baidu-a multinational technology company in China that offers services, including a search engine platform-to detect ocular fundus diseases. This AI fundus camera is capable of diagnosing glaucoma, diabetic retinopathy, and macular degeneration.

Despite preference of its alternatives, fluorescein angiography is often used as confirmatory test for a wide range of ophthalmic conditions. The technique provides accurate and high quality pictures which help in selecting efficient treatment regimen. In addition, the demand for tradition fluorescein angiography systems is still high in developing countries. This can be attributed to affordability and product availability.

Fluorescein Angiography Market Report Highlights:

  • Traditional fluorescein angiography dominated the market and accounted for the largest revenue share of 56.4% in 2024, attributed to the rising incidence of eye diseases, particularly diabetic retinopathy and age-related macular degeneration.
  • The age-related macular degeneration (AMD) application held the dominant position in the market, with the largest revenue share of 32.6% in 2024, owing to the increasing prevalence of this condition among the aging population.
  • The hospitals and clinics segment led the market and accounted for the largest revenue share of 63.9% in 2024 attributed to the increasing prevalence of eye diseases, particularly among the aging population.
  • The fluorescein angiography market in North America dominated the global market and accounted for the largest revenue share of 36.4% in 2024 attributed to the high prevalence of eye diseases, particularly diabetic retinopathy, which affects millions of individuals.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Fluorescein Angiography Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Fluorescein Angiography Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Traditional Fluorescein Angiography (FA)
    • 4.4.1. Traditional Fluorescein Angiography (FA) Market, 2018 - 2030 (USD Million)
  • 4.5. Confocal Scanning Laser Ophthalmoscopy (cSLO) FA
    • 4.5.1. Confocal Scanning Laser Ophthalmoscopy (cSLO) FA Market, 2018 - 2030 (USD Million)

Chapter 5. Fluorescein Angiography Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Age-related Macular Degeneration (AMD)
    • 5.4.1. Age-related Macular Degeneration (AMD) Market, 2018 - 2030 (USD Million)
  • 5.5. Diabetic Retinopathy
    • 5.5.1. Diabetic Retinopathy Market, 2018 - 2030 (USD Million)
  • 5.6. Retinal Vein Occlusion
    • 5.6.1. Retinal Vein Occlusion Market, 2018 - 2030 (USD Million)
  • 5.7. Uveitis and Retinal Vasculitis
    • 5.7.1. Uveitis and Retinal Vasculitis Market, 2018 - 2030 (USD Million)
  • 5.8. Choroidal Tumors
    • 5.8.1. Choroidal Tumors Market, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Fluorescein Angiography Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals and Clinics
    • 6.4.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Fluorescein Angiography Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Carl Zeiss Meditec, Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Type Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. NIDEK Co., Ltd.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Type Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Kowa Company Ltd.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Type Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Topcon Medical Systems, Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Type Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Optomed Oy (Ltd.)
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Type Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. CenterVue SpA
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Type Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Canon, Inc.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Type Benchmarking
      • 8.5.7.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Fluorescein Angiography Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 5 Global Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7 North America Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 9 North America Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 10 North America Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Mexico Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Mexico Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 23 Europe Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24 UK Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 25 UK Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 26 UK Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Germany Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Germany Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 France Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 France Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 France Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 35 Italy Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 Spain Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 38 Spain Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Norway Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 40 Norway Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 Norway Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Denmark Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Denmark Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Denmark Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Sweden Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 46 Sweden Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 47 Sweden Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Japan Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 Japan Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 54 Japan Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 55 China Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 56 China Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 57 China Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 India Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 India Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 India Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Australia Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 Australia Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 63 Australia Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 64 South Korea Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 66 South Korea Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Thailand Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 Thailand Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 Latin America Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Latin America Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 76 Brazil Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 90 UAE Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 92 UAE Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Fluorescein Angiography Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Type, Application Outlook (USD Million)
  • Fig. 10 End Use Outlook (USD Million)
  • Fig. 11 Competitive Landscape
  • Fig. 12 Fluorescein Angiography Market Dynamics
  • Fig. 13 Fluorescein Angiography Market: Porter's Five Forces Analysis
  • Fig. 14 Fluorescein Angiography Market: PESTLE analysis
  • Fig. 15 Fluorescein Angiography Market: Type Segment Dashboard
  • Fig. 16 Fluorescein Angiography Market: Type Market Share Analysis, 2024 & 2030
  • Fig. 17 Traditional Fluorescein Angiography (FA) Market, 2018 - 2030 (USD Million)
  • Fig. 18 Confocal Scanning Laser Ophthalmoscopy (cSLO) FA Market, 2018 - 2030 (USD Million)
  • Fig. 19 Fluorescein Angiography Market: Application Segment Dashboard
  • Fig. 20 Fluorescein Angiography Market: Application Market Share Analysis, 2024 & 2030
  • Fig. 21 Age-related Macular Degeneration (AMD) Market, 2018 - 2030 (USD Million)
  • Fig. 22 Diabetic Retinopathy Market, 2018 - 2030 (USD Million)
  • Fig. 23 Retinal Vein Occlusion Market, 2018 - 2030 (USD Million)
  • Fig. 24 Uveitis and Retinal Vasculitis Market, 2018 - 2030 (USD Million)
  • Fig. 25 Choroidal Tumors Market, 2018 - 2030 (USD Million)
  • Fig. 26 Others Market, 2018 - 2030 (USD Million)
  • Fig. 27 Fluorescein Angiography Market: End Use Segment Dashboard
  • Fig. 28 Fluorescein Angiography Market: End Use Market Share Analysis, 2024 & 2030
  • Fig. 29 Hospitals and Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 30 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • Fig. 31 Others Market, 2018 - 2030 (USD Million)
  • Fig. 32 Fluorescein Angiography Market Revenue, By Region
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 Regional Marketplace: Key Takeaways
  • Fig. 35 North America Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Country Dynamics
  • Fig. 37 U.S. Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Country Dynamics
  • Fig. 39 Canada Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico Country Dynamics
  • Fig. 41 Mexico Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 42 Europe Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 43 UK Country Dynamics
  • Fig. 44 UK Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany Country Dynamics
  • Fig. 46 Germany Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 47 France Country Dynamics
  • Fig. 48 France Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 49 Italy Country Dynamics
  • Fig. 50 Italy Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 51 Spain Country Dynamics
  • Fig. 52 Spain Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 53 Norway Country Dynamics
  • Fig. 54 Norway Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden Country Dynamics
  • Fig. 56 Sweden Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 57 Denmark Country Dynamics
  • Fig. 58 Denmark Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 60 Japan Country Dynamics
  • Fig. 61 Japan Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 62 China Country Dynamics
  • Fig. 63 China Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 64 India Country Dynamics
  • Fig. 65 India Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 66 Australia Country Dynamics
  • Fig. 67 Australia Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea Country Dynamics
  • Fig. 69 South Korea Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 70 Thailand Country Dynamics
  • Fig. 71 Thailand Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 73 Brazil Country Dynamics
  • Fig. 74 Brazil Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 75 Argentina Country Dynamics
  • Fig. 76 Argentina Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 77 MEA Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa Country Dynamics
  • Fig. 79 South Africa Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 80 Saudi Arabia Country Dynamics
  • Fig. 81 Saudi Arabia Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 82 UAE Country Dynamics
  • Fig. 83 UAE Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 84 Kuwait Key Country Dynamicss
  • Fig. 85 Kuwait Fluorescein Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 86 Company Categorization
  • Fig. 87 Company Market Position Analysis
  • Fig. 88 Strategic Framework